esmo breast cancer

Release time ：Dec-23,2024

The European Society for Medical Oncology (ESMO) Breast Cancer Guidelines serve as a pivotal international reference for the management of breast cancer, offering physicians the most current research findings and therapeutic advice. These guidelines suggest that treatment for breast cancer typically encompasses a range of modalities including surgery, radiotherapy, chemotherapy, endocrine therapy, and targeted therapy, with the specific approach tailored to the patient's condition, tumor biology, and overall health. For early-stage breast cancer patients, surgery is often the treatment of choice. The selection between breast-conserving surgery and total mastectomy is guided by tumor size and location. Following surgery, radiotherapy may be indicated based on pathology results to mitigate the risk of local recurrence. For hormone receptor-positive breast cancers, endocrine therapy is a critical component, with medications such as tamoxifen and aromatase inhibitors commonly utilized. Furthermore, for HER2-positive breast cancers, targeted therapies like trastuzumab can significantly enhance patient survival. In certain high-risk cases, chemotherapy may be indicated to reduce the risk of distant metastasis and recurrence. The management of breast cancer is inherently a multidisciplinary effort, necessitating personalized treatment plans that are informed by the patient's unique circumstances. Patients are advised to adhere to their physicians' guidance, engage in regular follow-ups and assessments to facilitate timely adjustments to treatment plans, and thereby enhance therapeutic outcomes. Additionally, maintaining healthy lifestyle practices, including a balanced diet, regular physical activity, and abstaining from smoking and excessive alcohol consumption, can aid in the body's recovery process.